ICE Bioscience provides in vitro pharmacology services centered on membrane proteins and safety-critical targets. Automated and manual patch clamp, GPCR assays, transporter studies, kinase profiling, and cell-based screening can be combined to characterize potency, selectivity, mechanism, and off-target activity. The company's cardiac safety capabilities help sponsors identify electrophysiological risk early and build evidence packages for more informed candidate selection.
ICE Bioscience
ICE Bioscience is a premier pharmacology-focused CRO specializing in ion channel, GPCR, and transporter screening, as well as comprehensive cardiac safety and profiling assays. Their robust automated patch-clamp and cell-based assay platforms provide essential in vitro data to help pharmaceutical companies de-risk drug candidates during early-stage discovery and preclinical testing.
The Latest Insights & Innovations from
ICE Bioscience
No items found.
Blog
Evolving Secondary Pharmacology: Functional, Dose-Response Safety Panels For Every Stage Of Discovery
September 22, 2025
Learn more
Blog
Spotlight on Innovation: How ICE Bioscience's Biology Building Block Platform Transforms Early Drug Discovery
September 3, 2024
Learn more
No items found.
No items found.